Simplex Trading
CBMG

Simplex Trading’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Simplex Trading’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-26,210
Closed – – 10583
2020
Q4 		$0 Buy
26,210
+25,847
+7,120% +$471K ﹤0.01% 9439
2020
Q3 		$0 Buy
+363
New +$6.1K ﹤0.01% 8894
2020
Q1 		– Sell
-2,644
Closed -$42.7K – 8598
2019
Q4 		$42K Buy
2,644
+2,545
+2,571% +$42.4K ﹤0.01% 5365
2019
Q3 		$1K Sell
99
-1,605
-94% -$21.6K ﹤0.01% 7125
2019
Q2 		$28K Sell
1,704
-2,099
-55% -$34.3K ﹤0.01% 5345
2019
Q1 		$65K Buy
3,803
+678
+22% +$12.3K ﹤0.01% 4786
2018
Q4 		$55K Buy
3,125
+2,712
+657% +$46.1K ﹤0.01% 4441
2018
Q3 		$7K Buy
413
+149
+56% +$3.06K ﹤0.01% 6647
2018
Q2 		$5K Sell
264
-1,758
-87% -$32.9K ﹤0.01% 6756
2018
Q1 		$35K Sell
2,022
-426
-17% -$7.8K ﹤0.01% 2804
2017
Q4 		$27K Buy
+2,448
New +$25.6K ﹤0.01% 3045
2015
Q4 		– Sell
-27
Closed – – 6437
2015
Q3 		$0 Buy
+27
New +$671 ﹤0.01% 6472

Simplex Trading's CBMG Position: Q1 2021 in Review

Simplex Trading sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 26,210 shares.

Simplex Trading first reported a position in CBMG in Q3 2015 and held it in 12 quarters. The position peaked at $65K in Q1 2019. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Simplex Trading reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Simplex Trading sold 26,210 Cellular Biomedicine Group, Inc. shares in Q1 2021.
  • Simplex Trading first reported a position in Cellular Biomedicine Group, Inc. in Q3 2015 and held it in 12 quarters.
  • Simplex Trading's Cellular Biomedicine Group, Inc. position peaked at $65K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.